Bruker BioSciences Nets $16.9M in Public Stock Offering | GenomeWeb
This article has been updated from a previous version, which reported the value of the total public offering, rather than the value of Bruker BioSciences' net proceeds.
NEW YORK (GenomeWeb News) — Bruker BioSciences today gained $16.9 million in proceeds from a public offering of its common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.